Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces
Open Access
- 17 July 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Health Services Research
- Vol. 10 (1), 211
- https://doi.org/10.1186/1472-6963-10-211
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- China's growing biomedical industryBiologicals, 2009
- Reform of how health care is paid for in China: challenges and opportunitiesThe Lancet, 2008
- Pharmaceutical Policy In ChinaHealth Affairs, 2008
- Issues in Drug Pricing, Reimbursement, and Access in China with References to Other Asia-Pacific RegionValue in Health, 2008
- Health service delivery in China: a literature reviewHealth Economics, 2007
- The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitalsHealth Policy and Planning, 2005
- Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, ChinaSocial Science & Medicine (1982), 2003
- 25 years of the WHO essential medicines lists: progress and challengesThe Lancet, 2003
- Association between health insurance and antibiotics prescribing in four counties in rural ChinaHealth Policy, 1999
- Drug Prescribing in Rural Health Facilities in China: Implications for Service Quality and CostTropical Doctor, 1998